Home › Client cases
Client cases

How we work in practice

These cases show the Liberi approach in practice. We value a tailored and personal approach with every client.
Track record

Deals our clients have announced

Full track record
Lexaria Bioscience and PharmCo (undisclosed pharma) agreement
Evaluation

Lexaria Bioscience

with PharmCo (undisclosed pharma)
Agreement to evaluate DehydraTECH with PharmCo’s proprietary molecules, with a path to licensing
Rumi Scientific and Enthorin Therapeutics deal
Option

Rumi Scientific

with Enthorin Therapeutics
Option to license RTX-7340, an IND-ready PDE2 inhibitor for Fragile X syndrome
Lexaria Bioscience and Pegbio deal
MTA

Lexaria Bioscience

with Pegbio
Material transfer agreement
IMPACT Therapeutics and Pharmanovia deal
Licensing

IMPACT Therapeutics

with Pharmanovia
Senaparib in 66 countries, up to €423.5 million in total deal value

Want results like these?

Book a call to discuss your asset or project with our team.